CareDx (CDNA) Cost of Revenue (2013 - 2026)

CareDx has disclosed Cost of Revenue across 14 years of filings, most recently posting $15.9 million for Q2 2026.

• In Q2 2026, Cost of Revenue rose 3.32% year-over-year to $15.9 million; the TTM figure through Jun 2026 stood at $64.5 million (up 10.91% YoY), while the FY2025 annual figure was $62.0 million, up 11.57% from the prior year.
• Cost of Revenue came in at $15.9 million for Q2 2026 at CareDx, down from $17.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $18.7 million in Q4 2022 to a low of $13.2 million in Q3 2023.
• Average Cost of Revenue over 5 years is $15.6 million, with a median of $15.3 million recorded in 2023.
• Year-over-year, Cost of Revenue slipped 26.01% in 2023 and climbed 18.26% in 2025.
• Over 5 years, Cost of Revenue stood at $18.7 million in 2022, then fell by 26.01% to $13.8 million in 2023, then rose by 3.04% to $14.2 million in 2024, then rose by 18.26% to $16.8 million in 2025, then fell by 5.37% to $15.9 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $15.9 million in Q2 2026, $17.1 million in Q1 2026, and $16.8 million in Q4 2025.